The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
N | Nervous system | |
2
|
N05 | Psycholeptics | |
3
|
N05C | Hypnotics and sedatives | |
4
|
N05CH | Melatonin receptor agonists | |
5
|
N05CH03 |
| Active Ingredient |
|---|
|
Tasimelteon is a circadian regulator that resets the master body clock in the suprachiasmatic nucleus (SCN). Tasimelteon acts as a Dual Melatonin Receptor Agonist (DMRA) with selective agonist activity at the MT1 and MT2 receptors. These receptors are thought to be involved in the control of circadian rhythms. |
| Document | Type | Information Source | |
|---|---|---|---|
| HETLIOZ Capsule | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| HETLIOZ Hard capsule | MPI, EU: SmPC | European Medicines Agency (EU) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.